Controlled release of artemisone for the treatment of experimental cerebral malaria.

导出 OA

翻译打印收藏纠错

作者： Jacob,Golenser ^[1] ; Viola,Buchholz ^[2] ; Amir,Bagheri ^[2] ; Abed,Nasereddin ^[3] ; Ron,Dzikowski ^[4] ; Jintao,Guo ^[3] ; Nicholas H,Hunt ^[5] ; Sara,Eyal ^[6] ; Natalia,Vakruk ^[5] ; Andreas,Greiner ^[7]

作者单位： Department of Microbiology and Molecular Genetics, The Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University of Jerusalem (HU)-Hadassah Medical School (HMS), Jerusalem, Israel. Golenser@md.huji.ac.il. ^[1] Macromolecular Chemistry II, University of Bayreuth, Universitätsstrasse 30, Bayreuth, Germany. ^[2] Department of Microbiology and Molecular Genetics, The Kuvin Center for the Study of Infectious and Tropical Diseases, The Hebrew University of Jerusalem (HU)-Hadassah Medical School (HMS), Jerusalem, Israel. ^[3] Al-Quds University, Abu Dis, The Palestinian Authority. ^[4] Department of Pathology and Bosch Institute, The University of Sydney, Sydney, Australia. ^[5] State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China. ^[6] Institute of Drug Research, School of Pharmacy, HU-HMS, Jerusalem, Israel. ^[7]

关键词 Artemisone Cerebral malaria Controlled release Plasmodium berghei ANKA Plasmodium falciparum